We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

WABC:NASDAQWestamerica Bancorporation Analysis

Data as of 2026-08-02 - not real-time

$60.15

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

Westamerica Bancorporation posted solid second‑quarter earnings, delivering net income of $27.4 million and EPS of $1.17, while announcing a quarterly cash dividend of $0.48 per share. The stock is trading above its 20‑day and 50‑day moving averages and also above the 200‑day SMA, signaling a bullish price trend despite a bearish MACD histogram and a neutral‑to‑slightly‑positive RSI in the mid‑50s. With a low beta around 0.4, the equity shows limited market‑wide volatility, though 30‑day price swings hover near 22 %, and recent volume has been tapering.
Fundamentally, the company trades at a PE near 13 versus an industry average of roughly 18, carries a dividend yield above 3 %, and the analyst consensus targets a price around $64, implying modest upside. The combination of a sustainable payout ratio, strong capital metrics and an “Extreme Greed” sentiment index supports a favorable outlook, while the modest max drawdown and limited regulatory exposure keep downside risk contained.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price above key moving averages indicating short‑term momentum
  • Bearish MACD histogram suggesting caution near resistance
  • Attractive dividend yield and low beta reducing immediate downside

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Undervalued relative PE and price‑to‑book versus peers
  • Projected upside to analyst target around $64
  • Sustainable dividend payout and solid earnings growth

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Stable, low‑volatility profile with low beta
  • Consistent dividend policy supporting total return
  • Strong balance‑sheet metrics and modest credit risk in the regional banking sector

Key Metrics & Analysis

Financial Health

Revenue Growth-2.70%
Profit Margin43.94%
P/E Ratio13.3
ROE12.49%
ROA1.91%
P/B Ratio1.6
Industry P/E18.0

Technical Analysis

TrendBullish
RSI55.1
Support$56.37
Resistance$63.61
MA 20$59.83
MA 50$58.23
MA 200$52.42
MACDBearish
VolumeDecreasing
Fear & Greed Index92.88

Valuation

Target Price$64.00
Upside/Downside6.40%
GradeUndervalued
TypeValue
Dividend Yield3.19%

Risk Assessment

Beta0.40
Volatility21.94%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.